PUT - SPRINTER OPEN END - FRESENIUS MEDICAL CARE Stock

Certificat

DE000VU94H17

Delayed Deutsche Boerse AG 07:52:52 2024-05-28 EDT
20.12 EUR -0.45% Intraday chart for PUT - SPRINTER OPEN END - FRESENIUS MEDICAL CARE
Current month-1.99%
1 month-11.05%
Date Price Change
24-05-28 20.12 -0.45%
24-05-27 20.21 +0.95%
24-05-24 20.02 -3.80%
24-05-23 20.81 +2.41%
24-05-22 20.32 +4.80%

Delayed Quote Deutsche Boerse AG

Last update May 28, 2024 at 07:52 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU94H1
ISINDE000VU94H17
Date issued 2023-07-19
Strike 58.89
Maturity Unlimited
Parity 1 : 1
Emission price 12.07
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 28.92
Lowest since issue 10.48
Spread 0.08
Spread %0.40%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.77 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.77%
Consensus